Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis

Gut Microbes

Volumn 7, Issue 5, 2016, Pages 414-423

  Rigby, Rachael J ^a   Carr, Jacquelyn ^b   Orgel, Kelly ^b   King, Stephanie L ^c   Lund, P Kay ^b   Dekaney, Christopher M ^b,c  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

apoptosis; bacteria; damage; doxorubicin; germ free; intestine

Indexed keywords

DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; DNA DAMAGE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; MORPHOMETRICS; MOUSE; NONHUMAN; ANIMAL; BACTERIUM; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENETICS; GERMFREE ANIMAL; GOBLET CELL; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PANETH CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BACTERIA; DOXORUBICIN; FEMALE; GASTROINTESTINAL MICROBIOME; GERM-FREE LIFE; GOBLET CELLS; INTESTINES; MICE; MICE, INBRED C57BL; PANETH CELLS;

EID: 84981532071     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1215806     Document Type: Article

References (34)

1. D.M.Keefe, J.Brealey, G.J.Goland, A.G.Cummins. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7; PMID:11034578; http://dx.doi.org/10.1136/gut.47.5.632
2. C.M.Dekaney, A.S.Gulati, A.P.Garrison, M.A.Helmrath, S.J.Henning. Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice. AmJPhysiol GastrointestLiver Physiol 2009; 297:G461-G70; http://dx.doi.org/10.1152/ajpgi.90446.2008
3. S.L.King, J.J.Mohiuddin, C.M.Dekaney. Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage. Am J Physiol Gastrointest Liver Physiol 2013; 305:G151-62; PMID:23660502; http://dx.doi.org/10.1152/ajpgi.00441.2012
4. M.Blaut, T.Clavel. Metabolic diversity of the intestinal microbiota:implications for health and disease. J Nutr 2007; 137:751s-5s; PMID:17311972
5. H.J.Wu, E.Wu. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012; 3:4-14; PMID:22356853; http://dx.doi.org/10.4161/gmic.19320
6. D.Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8:411-20; PMID:18469830; http://dx.doi.org/10.1038/nri2316
7. C.W.Ha, Y.Y.Lam, A.J.Holmes. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol 2014; 20:16498-517; PMID:25469018; http://dx.doi.org/10.3748/wjg.v20.i44.16498
8. S.Rakoff-Nahoum, J.Paglino, F.Eslami-Varzaneh, S.Edberg, R.Medzhitov. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis. Cell 2004; 118:229-41; PMID:15260992; http://dx.doi.org/10.1016/j.cell.2004.07.002
9. M.Alam, T.Midtvedt, A.Uribe. Differential cell kinetics in the ileum and colon of germfree rats. Scand J Gastroenterol 1994; 29:445-51; PMID:8036460; http://dx.doi.org/10.3109/00365529409096836
10. S.Kitajima, M.Morimoto, E.Sagara, C.Shimizu, Y.Ikeda. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim 2001; 50:387-95; PMID:11769541; http://dx.doi.org/10.1538/expanim.50.387
11. T.Watanabe, K.Higuchi, A.Kobata, H.Nishio, T.Tanigawa, M.Shiba, K.Tominaga, Y.Fujiwara, N.Oshitani, T.Asahara, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57:181-7; PMID:17639086; http://dx.doi.org/10.1136/gut.2007.125963
12. A.Kaczmarek, B.M.Brinkman, L.Heyndrickx, P.Vandenabeele, D.V.Krysko. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. J Pathol 2012; 226:598-608; PMID:21960132; http://dx.doi.org/10.1002/path.3009
13. R.J.Rigby, M.R.Hunt, B.P.Scull, J.G.Simmons, K.E.Speck, M.A.Helmrath, P.K.Lund. A new animal model of post-surgical bowel inflammation and fibrosis:the effect of commensal microflora. Gut 2009; 58(8):1104-12; PMID:19398439; http://dx.doi.org/10.1136/gut.2008.157636
14. S.Vaishnava, C.L.Behrendt, A.S.Ismail, L.Eckmann, L.V.Hooper. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 2008; 105:20858-63; PMID:19075245; http://dx.doi.org/10.1073/pnas.0808723105
15. D.A.Burden, N.Osheroff. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1998; 1400:139-54; PMID:9748545; http://dx.doi.org/10.1016/S0167-4781(98)00132-8
16. D.A.Gewirtz. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999; 57:727-41; PMID:10075079; http://dx.doi.org/10.1016/S0006-2952(98)00307-4
17. M.Fijlstra, M.Ferdous, A.M.Koning, E.H.Rings, H.J.Harmsen, W.J.Tissing. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer 2015; 23:1513-22; PMID:25376667; http://dx.doi.org/10.1007/s00520-014-2487-6
18. L.Rigottier-Gois. Dysbiosis in inflammatory bowel diseases:the oxygen hypothesis. ISME J 2013; 7:1256-61; PMID:23677008; http://dx.doi.org/10.1038/ismej.2013.80
19. C.P.Tamboli, C.Neut, P.Desreumaux, J.F.Colombel. Dysbiosis in inflammatory bowel disease. Gut 2004; 53:1-4; PMID:14684564; http://dx.doi.org/10.1136/gut.53.1.1
20. S.Malla, N.P.Niraula, B.Singh, K.Liou, J.K.Sohng. Limitations in doxorubicin production from Streptomyces peucetius. Microbiol Res 2010; 165:427-35; PMID:20116225; http://dx.doi.org/10.1016/j.micres.2009.11.006
21. F.Ballet, P.Vrignaud, J.Robert, C.Rey, R.Poupon. Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated perfused rat liver. Cancer Chemotherapy Pharmacol 1987; 19:240-5; PMID:3581417; http://dx.doi.org/10.1007/BF00252979
22. A.B.Roberts, B.D.Wallace, M.K.Venkatesh, S.Mani, M.R.Redinbo. Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity. Mol Pharmacol 2013; 84:208-17; PMID:23690068; http://dx.doi.org/10.1124/mol.113.085852
23. B.D.Wallace, A.B.Roberts, R.M.Pollet, J.D.Ingle, K.A.Biernat, S.J.Pellock, M.K.Venkatesh, L.Guthrie, S.K.O'Neal, S.J.Robinson, et al. Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity. Chem Biol 2015; 22:1238-49; PMID:26364932; http://dx.doi.org/10.1016/j.chembiol.2015.08.005
24. B.D.Wallace, H.Wang, K.T.Lane, J.E.Scott, J.Orans, J.S.Koo, M.Venkatesh, C.Jobin, L.A.Yeh, S.Mani, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010; 330:831-5; PMID:21051639; http://dx.doi.org/10.1126/science.1191175
25. S.Caballero, E.G.Pamer. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015; 33:227-56; PMID:25581310; http://dx.doi.org/10.1146/annurev-immunol-032713-120238
26. N.H.Salzman, C.L.Bevins. Dysbiosis–a consequence of Paneth cell dysfunction. Semin Immunol 2013; 25:334-41; PMID:24239045; http://dx.doi.org/10.1016/j.smim.2013.09.006
27. G.Nigro, R.Rossi, P.H.Commere, P.Jay, P.J.Sansonetti. The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration. Cell Host Microbe 2014; 15:792-8; PMID:24882705; http://dx.doi.org/10.1016/j.chom.2014.05.003
28. A.M.Stringer, R.J.Gibson, R.M.Logan, J.M.Bowen, A.S.Yeoh, J.Laurence, D.M.Keefe. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemotherapy Pharmacol 2009; 64:123-32; PMID:18998135; http://dx.doi.org/10.1007/s00280-008-0855-y
29. M.T.Abreu, L.S.Thomas, E.T.Arnold, K.Lukasek, K.S.Michelsen, M.Arditi. TLR signaling at the intestinal epithelial interface. J Endotoxin Res 2003; 9:322-30; PMID:14577850; http://dx.doi.org/10.1177/09680519030090050901
30. J.H.Niess, S.Brand, X.Gu, L.Landsman, S.Jung, B.A.McCormick, J.M.Vyas, M.Boes, H.L.Ploegh, J.G.Fox, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Sci (New York, NY) 2005; 307:254-8; http://dx.doi.org/10.1126/science.1102901
31. Z.Sun, X.Wang, R.Wallen, X.Deng, X.Du, E.Hallberg, R.Andersson. The influence of apoptosis on intestinal barrier integrity in rats. Scandinavian J Gastroenterol 1998; 33:415-22; PMID:9605264; http://dx.doi.org/10.1080/00365529850171053
32. D.Westermann, O.Lettau, M.Sobirey, A.Riad, M.Bader, H.P.Schultheiss, C.Tschope. Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor. Biol Chem 2008; 389:713-8; PMID:18627295; http://dx.doi.org/10.1515/BC.2008.070
33. C.I.Szalay, K.Erdelyi, G.Kokeny, E.Lajtar, M.Godo, C.Revesz, T.Kaucsar, N.Kiss, M.Sarkozy, T.Csont, et al. Oxidative/Nitrative stress and inflammation drive progression of doxorubicin-induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis-resistant rat strain. PLoS One 2015; 10:e0127090; PMID:26086199; http://dx.doi.org/10.1371/journal.pone.0127090
34. E.Marshman, P.D.Ottewell, C.S.Potten, A.J.Watson. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol 2001; 195:285-92; PMID:11673824; http://dx.doi.org/10.1002/path.967